%0 Online Multimedia %A Kelley, Robin K. %A Mollon, Patrick %A Blanc, Jean-Frédéric %A Daniele, Bruno %A Yau, Thomas %A Cheng, Ann-Lii %A Valcheva, Velichka %A Marteau, Florence %A Guerra, Ines %A Abou-Alfa, Ghassan K. %D 2020 %T Comparative Efficacy of Cabozantinib and Regorafenib for Advanced Hepatocellular Carcinoma %U https://adisjournals.figshare.com/articles/media/Comparative_Efficacy_of_Cabozantinib_and_Regorafenib_for_Advanced_Hepatocellular_Carcinoma/12213854 %R 10.6084/m9.figshare.12213854.v1 %2 https://adisjournals.figshare.com/ndownloader/files/22644332 %2 https://adisjournals.figshare.com/ndownloader/files/22643870 %2 https://adisjournals.figshare.com/ndownloader/files/22657895 %2 https://adisjournals.figshare.com/ndownloader/files/22643585 %2 https://adisjournals.figshare.com/ndownloader/files/22643822 %2 https://adisjournals.figshare.com/ndownloader/files/22643627 %2 https://adisjournals.figshare.com/ndownloader/files/22643759 %2 https://adisjournals.figshare.com/ndownloader/files/22643855 %K Cabozantinib %K CELESTIAL %K Hepatocellular carcinoma (HCC) %K Indirect treatment comparison %K Matching-adjusted indirect comparison (MAIC) %K Regorafenib %K RESORCE %K Second-line %K Systemic therapy %K Targeted therapy %K Plain Language Summary %X

The above digital features represent the opinions of the authors. These features consist of a graphical abstract, animated methods video, author-narrated video, plain language summary, slide deck, summary slide, and written scripts of the spoken content in both videos. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.


%I Adis Journals